FDA Authorizes Ocrevus Zunovo™: The Revolutionary MS Treatment
The U.S. Food and Drug Administration (FDA) has authorized Ocrevus Zunovo, a new subcutaneous injection, to treat relapsing and...
The Ultimate Guide to Unlocking the Secrets of Patient Monitoring’s Explosive Growth
The globally connected home medical monitoring devices market is expanding rapidly. In 2023, the number of such devices reached...
Drug Development Processes: Growing Demand Drives Growth
The global drug discovery informatics market is projected to reach $4.8 billion by 2030, expanding at a compound annual...
Breakthrough Contraceptive Revolutionizes Male Birth Control
Contraline, a biotechnology company, has secured an exclusive licensing agreement with the Population Council for NES/T Gel, an investigational...
SpectraWave’s HyperVue™ Revolutionizes Imaging, Secures $50M
SpectraWAVE, a medical imaging innovator, has secured $50 million in Series B funding led by Johnson & Johnson Innovation...
Unveiling the Power of Targeted Radionuclide Pharmaceuticals
Molecular Targeting Technologies (MTTI) and Brookline Capital Markets are collaborating at the 2nd Targeted Radionuclide Pharmaceuticals (TRPs) Supply Chain...
AI-Enhanced Gene Therapy Vector: A Revolutionary Advance for Muscle Disease Treatment
Genethon, a leading gene therapy research facility, has significantly progressed in developing a new generation of adeno-associated virus (AAV)...
GI Partner Acquires Majority Stake in eClinical Solutions
GI Partners has acquired a majority stake in eClinical Solutions, a leading provider of digital clinical software and services,...
Novel Twice-Yearly HIV Prevention Medication Lenacapavir Shows 96% Efficacy
Results from the Phase 3 PURPOSE 2 clinical trial have confirmed the effectiveness of Lenacapavir, an injectable HIV-1 capsid...
Unveiling Mavenclad’s Remarkable Benefits: Sustained Efficacy in MS
EMD Serono presented data at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, showcasing the...